ADENYLOSUCCINATE LYASE DEFICIENCY

Clinical trials for ADENYLOSUCCINATE LYASE DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new ADENYLOSUCCINATE LYASE DEFICIENCY trials appear

Sign up with your email to follow new studies for ADENYLOSUCCINATE LYASE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hope for rare brain disorder: old drug tested for autism and epilepsy

Disease control Completed

This study tested whether a drug called allopurinol could help people with a rare genetic condition called adenylosuccinate lyase deficiency (ADSL). The condition causes intellectual disability, autism, and epilepsy. Eight children and adults took the drug for a year to see if it…

Matched conditions: ADENYLOSUCCINATE LYASE DEFICIENCY

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ADENYLOSUCCINATE LYASE DEFICIENCY

Get alerted when new ADENYLOSUCCINATE LYASE DEFICIENCY trials appear

Hope for rare brain disorder: old drug tested for autism and epilepsy